— Know what they know.
Not Investment Advice

CTEV NYSE

Claritev Corporation
1W: +0.5% 1M: +7.6% 3M: +1.3% YTD: -30.4% 1Y: -17.9%
$21.67
-1.88 (-7.98%)
 
Weekly Expected Move ±27.0%
$6 $10 $14 $18 $21
NYSE · Healthcare · Medical - Healthcare Information Services · Alpha Radar Sell · Power 48 · $369.4M mcap · 7M float · 2.88% daily turnover · Short 50% of daily vol

Revenue Segmentation

By Product / Service

Income Trends

Revenue
$965M +3.7% ▲
5Y CAGR: +0.6%
Gross Profit
$267M -61.4% ▼
5Y CAGR: -15.5%
Operating Income
$45M +103.2% ▲
Net Income
-$284M +82.7% ▲
EPS (Diluted)
$-17.30 +83.0% ▲
EBITDA
$475M +147.2% ▲
5Y CAGR: +19.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$1.1B$1.1B$962M$931M$965M
YoY Growth+19.2%-3.4%-10.9%-3.2%+3.7%
Cost of Revenue$175M$204M$235M$239M$699M
Gross Profit$942M$876M$726M$691M$267M
Gross Margin84.3%81.1%75.5%74.3%27.6%
R&D Expenses$0$0$0$0$0
SG&A Expenses$151M$132M$136M$160M$222M
Operating Expenses$556M$1.2B$564M$2.1B$222M
Operating Income$386M-$363M$162M-$1.4B$45M
Operating Margin34.5%-33.6%16.8%-149.4%4.7%
Interest Expense$267M$303M$333M$326M$400M
Income Before Tax$135M-$561M-$107M-$1.8B-$373M
Tax Expense$33M$12M-$15M-$125M-$89M
Net Income$102M-$573M-$92M-$1.6B-$284M
Net Margin9.1%-53.1%-9.5%-176.9%-29.4%
EPS (Diluted)$6.40$-35.87$-5.69$-101.92$-17.30
EBITDA$815M$158M$652M-$1.0B$475M
Shares Outstanding16M16M16M16M16M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms